Skip to content

3D-based Sentinel Lymph Node Diagnosis and Biopsy in Head and Neck Cancer

3D-based Sentinel Lymph Node Diagnosis and Biopsy in Head and Neck Cancer - SLNOSCC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007719
Enrollment
30
Registered
2015-01-26
Start date
2015-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00 C01 C02 C03 C04 C05

Interventions

Group 1: Oral and Oropharyngeal Carcinoma stadium T1/2 andcN0. Preoperative a lymphscintigraphy is performed and intraoperative a sentinel lymph node biopsy via the SurgicEye(R)-tool is performed. Gro

Sponsors

Universitätsklinikum Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: EANM Practice Guideline: Patients with oral and oro-pharyngeal carcinoma with the stages cT1/T2 and indication for neck dissection or cT3/4 and indication for neck dissection - ipsilateral cN0 and non-midline tumour - bilateral cN0 and midline tumour - ipsilateral cN1 and contralateral cN0 with midline tumour cN0 has to be proven preoperatively by CT, NMR or Ultrasound. Depending on clinical importance patients with relapse or former operation or radiation might be included.

Exclusion criteria

Exclusion criteria: - pregnancy / lactation - severe psychiatric disease - no possible formal consent - missing formal consent - relapse and former operation - allergic reaction against Tc-99m-nanocoll

Design outcomes

Primary

MeasureTime frame
Aim of the study is to evaluate detection rate, sensitivity, specifity and negative predictive value for SLN in comparison with the values from the guidelines. This will be checked using a lymphscintigraphy and the SurgicEye(R)-tool.

Secondary

MeasureTime frame
In addition to the conventional gamma probe a freehand-SPECT will be used intraoperatively for measuring and depicting the distribution of the radionucleotide in the operation field. This might show especially advantages for this technique in detection of SLN especially in proximity to the tumour bed. Also the frequency the surgeon uses the 3D-presentation will be recorded.

Countries

Germany

Contacts

Public ContactUrs Müller-Richter

Klinik und Poliklinik für Mund-, Kiefer- und Plastische GesichtschirurgieZentrum für Zahn-, Mund- und KiefergesundheitUniversitätsklinikum Würzburg

mueller_u2@ukw.de004993120172000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026